Captopril: a free radical scavenger. 1989

M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
University Departments of Medicine and Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee.

The use of captopril in heart failure and hypertension is becoming increasingly accepted. Captopril has a sulphydryl group in its molecular structure. We wondered if this might confer free radical scavenging activity on the drug and have investigated this in an in vitro system. Results show that captopril is a free radical scavenger and we suggest that this action might be relevant in its use in heart failure and other vascular diseases.

UI MeSH Term Description Entries
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
October 1988, Clinical and investigative medicine. Medecine clinique et experimentale,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
January 2002, Doklady. Biochemistry and biophysics,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
October 1991, European journal of pharmacology,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
December 1991, Ophthalmic surgery,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
December 2002, Minerva cardioangiologica,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
November 2001, Experimental gerontology,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
August 1991, Atherosclerosis,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
April 1994, European journal of pharmacology,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
September 1990, Israel journal of medical sciences,
M Chopra, and N Scott, and J McMurray, and J McLay, and A Bridges, and W E Smith, and J J Belch
March 1998, Cell biochemistry and function,
Copied contents to your clipboard!